• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pliant Therapeutics, Inc. - Common Stock (NQ:PLRX)

1.040 -0.020 (-1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pliant Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types ↗
March 17, 2025
Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested in its Phase 1 trial. 
Via Benzinga
News headline image
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
March 17, 2025
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
March 15, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
March 13, 2025
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
What's going on in today's after hours session ↗
March 10, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
March 09, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
March 05, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future ↗
March 04, 2025
Pliant Therapeutics ends its Phase 2b IPF trial for bexotegrast, prompting a Needham downgrade to Hold due to limited catalysts and pipeline challenges. 
Via Benzinga
News headline image
This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday ↗
March 04, 2025
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
March 03, 2025
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results
March 03, 2025
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Here are the top movers in Monday's session. ↗
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder ↗
March 03, 2025
Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The company plans further data analysis. 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
March 03, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
March 03, 2025
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
February 18, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 13, 2025
Pliant has initiated assembly of outside panel of world-renowned experts to review BEACON-IPF trial data 
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Unusual volume stocks in Wednesday's session ↗
February 12, 2025
On Wednesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
News headline image
Which stocks are experiencing notable movement on Monday? ↗
February 10, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Crude Oil Rises Sharply; Manhattan Associates Shares Slide ↗
February 10, 2025
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
February 10, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss ↗
February 10, 2025
 
Via Benzinga
News headline image
This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗
February 10, 2025
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
February 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results ↗
February 10, 2025
 
Via Benzinga
Topics Stocks
News headline image
Monday's pre-market session: top gainers and losers ↗
February 10, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues ↗
February 10, 2025
Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed bexotegrast reduced lung collagen. 
Via Benzinga
News headline image
Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
February 10, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
February 10, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap